Lhasa Limited shared knowledge shared progress

How to better anticipate and mitigate adverse drug reactions [an infographic]

Read time: less than 5 minutes

Effiris blog image Feb2021

Are you interested in collaboratively using data to predict and avoid adverse drug reactions? The Effiris consortium - currently composed of Takeda, GSK and UCB - is working to achieve just that.

The project aims to help pharmaceutical organisations accelerate drug discovery through machine learning.

Many readers will be very familiar with the fact that one of the biggest challenges in building accurate predictive models within the pharmaceutical drug discovery space, is the limited availability of high-quality data, due to the often-confidential nature of the data. The Effiris privacy preserving data sharing methodology aims to overcome this obstacle.  

Read more about the Effiris approach and progress in the infographic below.

height=

If you have read this far, you might also be interested in joining our free Effiris webinar on Thursday 18th February - register or catch up here.

________________

Did you enjoy this blog? Please let us know.

What else would you like us to write about? Please let us know.

About this article

Category:

Read Time:

Clock: less than 5 minutesless than 5 minutes

Related Products:

© 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.